• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 160NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX 160NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Model Number 0500316E
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/29/2022
Event Type  malfunction  
Manufacturer Narrative
Plant investigation: the plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event Description
A user facility reported that an internal dialyzer blood leak occurred five minutes after initiation of a patient¿s hemodialysis treatment.It was reported that the blood was observed in the dialysis compartment and outside the membranes of the arterial head.The machine, a fresenius 4008s, alarmed appropriately with a blood leak alert.Blood leak test strips were not used.No further damage and/or defects were noted.It was unknown if fresenius bloodlines were being utilized for the treatment or if the patient¿s blood was returned.The estimated blood loss (ebl) was reportedly 20 ml.It was confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The patient was able to complete treatment on the same machine after re-setting up supplies.The dialyzer was reported to be discarded and no longer available for manufacturer evaluation.A photo was provided for the investigation.
 
Manufacturer Narrative
Plant investigation: the reported complaint was not confirmed as the complaint device was not returned for manufacturer evaluation.Three photographs were provided for the investigation.Each photo shows a different angle of a used dialyzer.There is blood visible outside of the fiber bundle in the dialysate fluid indicative of an internal leak.The source of the leak is not visible in any of the photographs.A production records review was performed on the reported lot.An investigation of the device history records (dhr) was conducted by the manufacturer.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.The complaint is confirmed.The reported lot number passed pyrogen testing, was within sterilization dosage parameters and passed all release criteria.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program, in order to assess and improve our products and processes.Capas 2018-0171 (vision systems) and 2018-0161 (blood leak reduction) are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.
 
Event Description
A user facility reported that an internal dialyzer blood leak occurred five minutes after initiation of a patient¿s hemodialysis treatment.It was reported that the blood was observed in the dialysis compartment and outside the membranes of the arterial head.The machine, a fresenius 4008s, alarmed appropriately with a blood leak alert.Blood leak test strips were not used.No further damage and/or defects were noted.It was unknown if fresenius bloodlines were being utilized for the treatment or if the patient¿s blood was returned.The estimated blood loss (ebl) was reportedly 20 ml.It was confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The patient was able to complete treatment on the same machine after re-setting up supplies.The dialyzer was reported to be discarded and no longer available for manufacturer evaluation.A photo was provided for the investigation.
 
Manufacturer Narrative
Plant investigation: the complaint device was not returned for manufacturer evaluation.The reported complaint was confirmed with three photographs provided for the investigation.Each photo shows a different angle of a used dialyzer.There is blood visible outside of the fiber bundle in the dialysate fluid indicative of an internal leak.The source of the leak is not visible in any of the photographs.A production records review was performed on the reported lot.An investigation of the device history records (dhr) was conducted by the manufacturer.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.The complaint is confirmed.The reported lot number passed pyrogen testing, was within sterilization dosage parameters and passed all release criteria.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program, in order to assess and improve our products and processes.Capas 2018-0171 (vision systems) and 2018-0161 (blood leak reduction) are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.
 
Event Description
A user facility reported that an internal dialyzer blood leak occurred five minutes after initiation of a patient¿s hemodialysis treatment.It was reported that the blood was observed in the dialysis compartment and outside the membranes of the arterial head.The machine, a fresenius 4008s, alarmed appropriately with a blood leak alert.Blood leak test strips were not used.No further damage and/or defects were noted.It was unknown if fresenius bloodlines were being utilized for the treatment or if the patient¿s blood was returned.The estimated blood loss (ebl) was reportedly 20 ml.It was confirmed there was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The patient was able to complete treatment on the same machine after re-setting up supplies.The dialyzer was reported to be discarded and no longer available for manufacturer evaluation.A photo was provided for the investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLUX 160NRE DIALYZER FINISHED ASSY.
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer (Section G)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key14915350
MDR Text Key303305383
Report Number0001713747-2022-00234
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100149
UDI-Public00840861100149
Combination Product (y/n)N
Reporter Country CodeMX
PMA/PMN Number
K162488
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 12/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/05/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number0500316E
Device Catalogue Number0500316E
Device Lot Number22AU06019
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Date Manufacturer Received12/01/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/20/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FRESENIUS 4008S MACHINE; FRESENIUS 4008S MACHINE; FRESENIUS 4008S MACHINE
Patient Age71 YR
Patient SexFemale
Patient Weight36 KG
-
-